Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(41)
•••
Comment by JAKPUG4LIFEon Jun 10, 2020 11:42am
46 Views
Post# 31133573

RE:my own opinion though

RE:my own opinion thoughLol, comedy
StarPower wrote:
Everyone assumes FSD is bad just because market conditions of 2018 and cannabis bubble burst doesn’t mean FSD Management are evil I think during that time they actually wanted to become the world’s biggest facility but due to financing I don’t think banks were ready to lend them money to advance their efforts when there are over 100 companies doing the same thing. Luckily they didn’t go through with the grow facility at this time they respect institutional money and have the smarts, don’t need to invest into something that will result in massive debt and over supplied market. If USA ever legalized on the federal level im sure EU would follow as well, then it would make sense to build that to supply recreational market. Doubt that is happening any time soon, thus based on my own opinion biotech is the future not recreational weed unless USA legalizes until then it’s a dream.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities